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16	 years	 (range	 5-33).	 Pain	 was	 the	 most	 common	 presenting	 feature.	 A	 histological	
diagnosis	 of	 OO	 was	 confirmed	 in	 5	 of	 the	 9	 patients	 with	 a	 suspected	 diagnosis	 of	 OO	
preoperatively.	 Of	 the	 4	 patients	 whose	 diagnosis	 changed	 after	 the	 procedure	 the	
diagnoses	 included	 a	 benign	 spindle	 cell	 lesion	 (1),	 a	 benign	 fibrous	 histiocytoma	 (1),	
subacute	 osteitis	 and	 an	 osteochondral	 defect	 with	 geode	 cyst	 formation	 (1).	 Of	 the	 2	
patients	where	OO	was	 not	 suspected	 preoperatively,	 chondroblastoma	was	 confirmed	 in	




providing	 a	 histological	 diagnosis	 and	 definitive	 treatment	 through	 a	 minimally	 invasive	
approach.	This	 is	especially	useful	 in	 less	accessible	regions	of	the	skeleton	as	 it	provides	a	
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Patient	 information	 was	 obtained	 from	 a	 prospective	 database	 at	 Groote	 Schuur	 and	
Vincent	 Pallotti	 Hospitals.	 The	 Ethics	 committee	 approved	 these	 databases	 and	 their	







































Method:	 A	 retrospective	 folder	 review	 of	 patients	 treated	 in	 a	 large	 academic	 hospital	 in	





Pain	 was	 the	 most	 common	 presenting	 feature.	 A	 histological	 diagnosis	 of	 OO	 was	
confirmed	 in	 5	 of	 9	 patients	 with	 a	 suspected	 diagnosis	 of	 OO	 preoperatively.	 Of	 the	 4	
patients	 whose	 diagnosis	 changed	 after	 the	 procedure	 the	 diagnoses	 included	 a	 benign	
spindle	 cell	 lesion,	 a	 benign	 fibrous	 histiocytoma,	 subacute	 osteitis	 and	 an	 osteochondral	
defect	 with	 geode	 cyst	 formation.	 Of	 the	 2	 patients	 where	 OO	 was	 not	 suspected	
preoperatively,	 chondroblastoma	was	 confirmed	 in	 one	while	 a	 benign	 spindle	 cell	 lesion	
was	 reported	 in	 the	 other.	 	 Overall	 histological	 yield	 was	 thus	 100%.	 There	 were	 no	
complications	 or	 repeat	 procedures	 at	 a	 median	 follow	 up	 of	 42	 months	 (range	 30-52	
months).	
Conclusion:	 CT	 guided	 intralesional	 curettage	 is	 a	 safe	 and	 minimally	 invasive	 technique.	
This	 is	especially	useful	 in	 less	accessible	 regions	of	 the	skeleton	as	 it	provides	a	means	of	
















part	 to	 the	 profound	 pain	 and	 disability	 it	 causes	 patients.	 It	 is	 also	 the	 most	 common,	
accounting	 for	 12%	 of	 primary	 benign	 bone	 tumours.[1]	 Its	 differential	 diagnosis	 includes	
osteoblastoma,	 chondroblastoma,	 enchondroma	 and	 chondromyxoid	 fibroma	 as	 well	 as	
traumatic	 conditions,	 such	 as	 stress	 fracture,	 or	 infection,	 in	 the	 case	 of	 a	 Brodie's	
abscess.[2]	 The	 natural	 history	 of	 an	OO	 is	 that	 of	 spontaneous	 resolution	 and	malignant	
transformation	has	 never	 been	described.[3-6]	 Symptomatic	 relief	 can	be	 gained	with	 the	
regular	use	of	nonsteroidal	 anti-inflammatory	drugs	 (NSAID’s)	but	 side	effects,	particularly	
gastric	 irritation,	 may	 hamper	 this	 strategy.[4-6]	 In	 refractory	 cases	 surgical	 excision	 is	
usually	 curative.[7]	 This	may	be	performed	 in	 a	number	of	ways;	 either	by	open	marginal	
excision	 or	 through	 less	 invasive	 techniques,	 performed	 under	 image	 guidance,	 such	 as	
direct	 curettage,	 laser	 photocoagulation	 and	 radiofrequency	 ablation	 with	 or	 without	
biopsy.[8]	 Novel	 techniques	 such	 as	 magnetic	 resonance-guided	 focused	 ultrasound	
(MRgFUS)	[9-11]	and	arthroscopic	excision	are	also	currently	being	evaluated.[12-15]		
	
While	 the	use	of	 novel	 techniques	 to	 deal	with	 small	 benign	bone	 tumours	 are	 becoming	










was	 performed.	 Included	 were	 all	 patients	 who	 underwent	 minimally	 invasive	 CT	 guided	
intralesional	excision	of	a	primary	benign	bone	tumour	between	March	2012	and	May	2016.	
Excluded	 were	 extraosseous	 lesions,	 inadequate	 follow-up	 (less	 than	 1	 year),	 incomplete	
records	and	lesions	that	were	malignant	or	located	outside	of	bone.	Patient	demographics,	
details	 of	 presentation,	 clinical	 information	 and	 outcome	 following	 treatment	 were	
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informed	consent	prior	 to	 surgery.	Patients	were	admitted	on	 the	morning	of	 surgery	and	
discharged	on	the	same	day.	Prophylactic	Cefazolin	1g	or	Clindamycin	600mg,	in	the	case	of	
Penicillin	 allergy,	 was	 administered.	 Anaesthesia	 was	 induced	 in	 theatre	 after	 which	 the	
patient	was	 transferred	 to	 the	 radiology	 suite	where	 a	 threaded	 tipped	Kirschner	wire	 (K-
wire)	 was	 inserted	 by	 a	 qualified	 radiologist	 under	 sterile	 conditions	 using	 CT	 guidance	
(Figure	4	&	5).	The	K-wire	was	then	cut	to	within	3	cm	of	the	skin	and	covered	with	a	sterile	
dressing.	 Back	 in	 theatre	 a	 full	 standard	 preparation	 and	 draping	 of	 the	 patient	 was	
performed.	A	small	skin	incision	was	made	to	allow	a	6mm	cannulated	drill	bit	to	be	passed	
over	 the	K-wire	 and	drilled	down	 into	 the	 lesion.	 The	K-wire	was	 lubricated	with	 K-Y	 Jelly	
(Reckitt	 Benckiser,	 Berkshire,	 UK)	 to	 prevent	 it	 from	 spinning	 with	 the	 drill	 bit	 and	
inadvertently	 advancing	 beyond	 the	 lesion.	 A	 long-handled	 curette	 was	 passed	 down	 the	
drill	hole	 (after	 removing	 the	K-wire)	and	 the	contents	of	 the	 lesion	curetted	and	 sent	 for	
histology	and	microbiological	culture.	Fluoroscopy	was	used	to	confirm	the	position	of	the	K-
wire	 and	 ensure	 adequacy	 of	 the	 curettage.	 Allomatrix	 (Wright	 Medical,	 Middlesex,	 UK)	
demineralized	bone	matrix	 (DBM)	 calcium	 sulphate	putty	was	 injected	 into	 the	 cavity	 and	































of	6	months	 (range	1	–	26	months).	 In	4	of	 the	11	 (36%)	patients	 the	pain	was	associated	
with	a	limp,	7	of	the	11	(63%)	complained	of	night	pain	and	3	(27%)	had	activity	related	pain.	
Six	 (54%)	 patients	 reported	 pain	 relief	 with	 NSAID	 use.	 All	 5	 of	 the	 patients	 with	 OO	
complained	of	night	pain	and	3	of	these	reported	transient	relief	of	symptoms	with	NSAID	
use.	 	One	patient	with	a	proximal	 tibia	OO	had	mechanical	knee	symptoms	 including	knee	
locking	 and	 an	 effusion.	 This	 patient	 had	 a	 delay	 in	 diagnosis	 of	 26	 months	 as	 meniscal	
pathology	was	suspected	and	the	initial	magnetic	resonance	image	(MRI)	failed	to	diagnose	













I.	No	 lesion	 was	 larger	 than	 20mm	 in	 diameter	 with	 a	 median	 of	 9mm	 (range	 4-20mm).	
Microbial	 culture	was	negative	 in	all	 cases.	Nine	patients	were	 thought	 to	have	an	OO	on	
clinical	and	radiological	assessment	preoperatively.	 In	2	of	 these	patients	subacute	osteitis	
was	 included	 in	 the	 differential	 diagnosis.	 Histological	 examination	 confirmed	 OO	 in	 5	 of	





have	 a	 chondroblastoma	 of	 the	 calcaneus	 that	 was	 confirmed	 on	 biopsy	 while	 the	 other	
patient,	with	 a	 lesion	 in	 the	 ilium	adjacent	 to	 the	 sacroiliac	 joint,	 had	a	wider	 radiological	




The	 median	 follow-up	 time	 was	 42	 months	 (range	 30-52	 months).	 No	 patients	 had	
recurrence	 of	 symptoms,	 surgical	 complications	 or	 secondary	 surgical	 procedures.	 In	 the	
patients	 who	 had	 histologically	 confirmed	 OO	 (n=5),	 all	 patients	 had	 pain	 relief	 following	
surgery	and	remained	symptom	free	with	no	radiological	signs	of	recurrence,	as	did	5	of	the	
6	 patients	 with	 other	 diagnoses.	 The	 patient	 whose	 symptoms	 did	 not	 resolve	 had	 a	







Localised	 pain	 is	 the	 most	 common	 primary	 presenting	 complaint	 (85%	 of	 cases)	 and	 is	
classically	described	as	being	worse	at	night	and	relieved	by	NSAIDs.[18,	19]	Night	pain	was	
present	in	all	of	our	patients	with	OO	as	well	2	patients	with	other	tumour	diagnoses.	Six	of	
the	 11	 patients	 reported	 symptomatic	 relief	 with	 NSAID	 use.	 Of	 these	 6,	 3	 had	 a	 final	
diagnosis	 of	 an	 OO.	 The	 natural	 history	 of	 OO	 is	 to	 resolve	 over	 time	 and	 up	 to	 40%	 of	
	 48	
patients	 experience	 long	 term	 relief	 with	 NSAID’s.[20]	 For	 this	 reason	 some	 authors	
advocate	 non-operative	 management.[5]	 All	 patients	 in	 our	 series	 had	 failed	 a	 trial	 of	




the	 lower	 limbs,	 especially	 in	 the	metaphyseal	 region	 of	 the	 femur	 and	 tibia.[18,	 19]	We	
noted	 similar	 findings	 of	 age	 and	 location	 in	 our	 case	 series,	 but	 found	 that	 the	 clinical	






condition	and	wide	differential	 for	 limb	pain	 in	 the	active	young	patient.	Cantwell	noted	a	
mean	 delay	 to	 diagnosis	 of	 16	 months.[21]	 Richardson	 describes	 a	 missed	 case	 of	 intra-
articular	OO	in	the	hip	of	an	18	year	old	patient	where	the	diagnostic	delay	was	2	½	years	
due	 to	 inadequate	 imaging	 and	 failing	 to	 suspect	 the	 diagnosis.[22]	 In	 our	 series	 a	 young	
male	 sportsman	with	 a	 proximal	 tibia	OO	 initially	 presented	with	 knee	 pain	 and	meniscal	
symptoms.	 An	 MRI	 failed	 to	 diagnose	 an	 OO	 and	 the	 presumed	 cause	 of	 his	 pain	 was	
meniscal	pathology.	After	a	failed	course	of	conservative	treatment,	a	repeat	MRI	and	a	CT	
scan	 diagnosed	 an	 OO	 that	 was	 successfully	 treated	 by	 the	 method	 described	 above.			
Skeletal	 imaging	 plays	 a	 major	 role	 in	 the	 diagnosis	 of	 OO.	 Initially	 plain	 X-rays	 are	 the	
modality	of	choice	due	to	the	relatively	low	cost	and	radiation	exposure	but	the	diagnostic	
yield	is	far	superior	with	CT.[23-25]	The	potential	advantage	of	MRI	over	CT	is	in	decreased	








Microbiological	 culture	 was	 negative	 in	 all	 patients,	 despite	 one	 patient	 having	 subacute	
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The	 most	 common	 indication	 for	 surgery	 is	 failed	 medical	 management.[17]	 Other	
indications	 include	 prevention	 of	 growth	 deformity	 in	 intra-articular	 or	 juxta-epiphysial	
lesions	and	the	need	for	histological	confirmation	of	the	diagnosis.[18]	While	some	authors	
advocate	 treatment	 without	 biopsy[8]	 we	 believe	 it	 is	 an	 essential	 part	 of	 management.	





to	4,5%	of	 cases	 [31]	 and	a	 recurrence	 rate	of	up	 to	9%.[32]	 Less	 invasive	procedures	are	
therefore	 preferred.[33]	 Open	 intra-lesional	 excision	 is	 less	 invasive,	 results	 in	 less	 local	
morbidity	and	a	more	rapid	recovery.[31,	32,	34]	Intra-operative	imaging	can	be	augmented	





achieved	 in	 84-100%	 and	 importantly	 histological	 yield	 is	 reported	 between	 50	 and	




described:	an	RFA	only	 technique	and	a	 combined	 technique,	biopsy	and	RFA.	Histological	
yield	ranges	from	17-100%	(mean	55%)	with	the	combined	technique	as	the	entire	lesion	is	
not	 available	 for	 examination.[17]	 Lanzo	 et	 al	 grouped	 data	 from	 27	 published	 articles	







is	 no	 ionizing	 radiation	 but	 it	 may	 be	more	 expensive	 and	 is	 not	 available	 in	 all	 centres.	
Histological	specimens	are	not	usually	sent.	
		
Overall	 the	 rate	of	 complications	 and	 cure	 for	 the	percutaneous	 image	 guided	 techniques	









(both	 femoral	 and	 acetabular	 sided	 lesions),	 knee,	 shoulder,	 ankle	 and	 talus.[12-15]	
Proposed	 advantages	 are	 the	 minimally	 invasive	 surgical	 approach	 and	 limited	 articular	




currently	 under	 investigation.[37]	 It	 is	 a	 closed	 technique	 and	 thus	 avoids	 some	 of	 the	
complications	associated	with	a	surgical	procedure	but	regional	or	general	anaesthesia	is	still	
necessary	as	the	procedure	is	painful.		In	a	series	of	29	patients	Geiger	and	colleagues	report	





The	 cost	 of	 health	 care	 in	 both	 developed	 and	 developing	 economies	 is	 increasing	 at	 an	
alarming	 rate	 and	 the	 importance	 of	 cost	 containment	 cannot	 be	 overemphasized.[39]	
Moser	 et	 al	 found	 the	 cost	 of	 consumables	 for	 Laser	 photocoagulation	 and	 RFA	 to	 be	
equivalent,[11]	 while	 Hoffman	 et	 al	 found	 RF	 ablation,	 which	 was	 performed	 as	 an	
outpatient	procedure,	to	be	the	most	cost	effective	with	a	base	price	of	$6	583.00	USD	(R81	
	 51	
359.00).	Open	resection	$13	826.00	USD	 (R170	876.00),	 intralesional	 resection	$10	857.00	
USD	(R13	4182.00)	and	CT	guided	drill	curettage	$8	589.00	USD	(R106	150.00)	were	all	more	
expensive.[36]	 However	 these	 results	 from	 Germany	 cannot	 be	 extrapolated	 to	 other	
regions	 as	 in	 different	 economies	 certain	 elements	 of	 the	 treatment	 package	 may	 have	
relatively	different	 financial	weightings.	For	example	a	procedure,	which	takes	 less	 theatre	
time	 but	 uses	 more	 expensive	 consumables,	 may	 be	 cost	 effective	 in	 one	 country	 while	
being	 unaffordable	 in	 another.	 Also	 of	 note	 is	 that	 cost	 of	 CT,	 MRI,	 fluoroscopy,	 theatre	
time,	anaesthetic,	hospital	stay,	postoperative	rehabilitation	and	time	away	from	work	have	













surgical	 management.	 For	 the	 included	 patients,	 CT	 guided	 biopsy	 and	 intralesional	





















































































































































































1	 19	 Male	 Calcaneus	 3	 Chondroblastoma	 Chondroblastoma	
2	 20	 Female	 Proximal	
femur	
26	 Osteoid	Osteoma	 Osteoid	Osteoma	
3	 19	 Male	 Proximal	
tibia	
6	 Osteoid	Osteoma	 Osteoid	Osteoma	
4	 33	 Female	 Talus	 13	 Osteoid	Osteoma	 OCD/Geode	cyst	
5	 16	 Male	 Prox.	tibia	 18	 Osteoid	Osteoma	 Osteoid	Osteoma	
6	 11	 Female	 Calcaneus	 3	 Osteoid	Osteoma	 Benign	fibrous	
histiocytoma	




8	 19	 Female	 Proximal	
femur	
3	 Osteoid	Osteoma	 Osteoid	Osteoma	

















Table	 II:	Descriptions	of	 interventional	 techniques	 for	 the	 treatment	of	benign	 lesions	of	
bone	



































































































































































































































































































































































































































































































































































































































































































































































                                  DRC PROTOCOL 
Minimally invasive CT-guided excision of benign bone tumours. 
 
Investigators: Dr T Sluis-Cremer, Dr T.L. Hilton, Dr K Hosking 
Department of Orthopeadic Surgery 
University of Cape Town 
Groote Schuur Hospital & Vincent Pallotti Hospital 
 
Introduction and aim of study 
 
Osteoid osteoma and osteoblastoma are benign osteogenic tumours, and together are 
the most common benign bone forming lesions accounting for 3% of all bone 
tumours. These occur most commonly in young male patients and aside from the 
spine are found predominantly in the metaphyseal regions of the lower limbs. The 
hallmark feature is that of lytic nidus circumscribed by an area of sclerotic bone. 
Histologically the nidus is composed of osteoid. Osteoblastoma and osteiod osteoma 
are very similar lesions with the only difference being that in osteoblastoma, which 
may be locally aggressive, the nidus is usually larger than the 15mm size of osteiod 
osteoma and unlike osteiod osteoma is usually painless. The pain caused by osteoid 
osteoma is worse at night and is dramatically relieved by non-steroidal anti-
inflammatory medications (NSAID's). There is no risk of malignant transformation 
and the natural history is thought to be that of resolution. Management is either 
medical, with NSAIDS, or surgical. The surgical options included en-block excision, 
percutaneous ablation using either radiofrequency induced thermal coagulation, or 
intra-lesional injection of phenol, cryotherapy or laser photocoagulation and CT 
guided intra-lesional excision. CT guided excision involves anaesthetizing the patient, 
transfer to CT scanner, insertion of a guidewire under CT guidance by the radiologist. 
 The patient is then transferred back to theatre where a small incision is made in the 
skin and a drill placed over the guidewire to open the cortex of the involved bone. A 
curette is then used to excise the lesion. These techniques may be augmented with 
bone graft to fill the resultant defect. CT guided intra-lesional excision has the 
advantage of providing a histological diagnosis through a minimally invasive 
approach, especially in less accessible regions while maintaining the structural 
integrity of the bone from which the lesion is excised. The aim of this study is to 
review the clinical outcomes of patients treated with CT guided intra-lesional excision 




We hypothesize that percutaneous CT-guided intra-lesional excision of benign bone 
forming tumours is an acceptable surgical technique with low incidence of 
complications. It successfully alleviates symptoms with the additional benefit of 
histological confirmation of the diagnosis. 
 
Aims and objectives 
 
Aim: 
Main aim to describe case series – procedure 





Describe the imaging done pre-diagnosis 
measure pain resolution  immediate post op and during follow up 
Measure complications – surgical 
- During follow up 
- Last follow up 




All patients who were treated for benign osteogenic tumours (osteoid osteoma and 
osteoblastoma) by CT-guided percutaneous intra-lesional excision at Groote Schuur 
and Vincent Pallotti Hospitals will be included in the study population. Clinical case 
notes, Radiology and Laboratory results will be reviewed retrospectively. Patients 
with incomplete records or patients with these tumours who were treated by methods 









A search of the GSH and Vincent Pallotti tumour databases will find all patients who 
were treated by CT-guided intralesional resection of osteoid osteoma and 
osteoblastoma. All guide wires were placed by a consultant radiologist. A 
retrospective review of their records will be performed for the following parameters: 
 
1. Age at presentation 
a.  Often the diagnosis is not one of osteoid osteoma. Age will help us 
correlate with diagnosis 
2. Site of involvement (clinically and radiologically) 
a. To ensure that we are consistent with current literature describing the 
more common sites of osteiod osteoma 
3. Size of lesion 
a. To distinguish between osteoid osteoma and osteoblastoma. <1.5cm 
osteiod osteoma, >1.5cm osteoblastoma. 
4. Radiological features 
5. Histological diagnosis 
6. Pre-operative symptoms Yes/No 
7. Post-operative resolution of symptoms Yes/No 
8. Intra-operative, early post-operative and late complications 
a. Possible: 





iv. Incomplete excision 
9. Clinical and radiological outcome 
a. Clinical outcomes will include resolution of preoperative symptoms. 
b. Radiological outcomes will include excision of lesion and subsequent 
new bone formation. 
At what time interval are you measuring these outcomes? 1 yr ? 1 month? What if this 
info is missing from the folder? Are you going to exclude every patient whose info 
isn’t complete? Bc then you will have a lot of exclusions. 
 
Analysis of the data 
 
An osteoid osteoma is a rare lesion and the lesions that benefit from CT guided 
excision are fewer still. We expect between 10 and 20 cases. Descriptive analysis of 
the data will be performed. 
 
Data collection will take approximately 1 month, with analysis of the data a further 
month, write up and submission 2 – 3 months. 
 
During analysis of the results we will be looking at the following points; 
 
➢ Pre-operative vs post-operative visual analogue pain score  
➢ Proportion of recurrence 
➢ Incidence of infection 
➢ Number of complications 
➢ Number of re-operations 






Report of findings 
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Results will be submitted for publication in peer review journals. Results will also be 





This is purely a retrospective study utilising available clinical notes and radiographs. 
No intervention is to be performed on any patient outside of acceptable clinical 
practice. No extra risks will be entailed by any of the subjects within the study. No 
patients will be identified by name or hospital number and every effort will be made 
to protect their privacy. There are no immediate benefits to the study subjects as this 
is a retrospective analysis. The knowledge gained will influence the future 
management of similar patients seen within the context of locally available resources 
and expertise.  
 
Budget and funding 
 
Costs will be incurred by the investigators involved in the study. There is no financial 
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e.	Description	of	surgical	Margins	for	excision	of	bone	tumours	(Enniking)	
Types	of	surgical	margins	for	the	resection	of	bone	tumours	
According	to	Enniking	surgical	margins	for	the	resection	of	bone	tumours	may	be	divided	into	four	groups	
1. Intralesional	resection	
Margins	are	entirely	within	the	tumour,	not	all	tumour	material	is	excised	
	
2. Marginal	resection	
Margins	are	situated	at	the	immediate	extent	of	the	tumour	
	
3. Wide	resection	
Margins	include	the	tumour	and	a	cuff	off	normal	tissue	
	
4. Radical	resection	
Margins	include	the	tumour	and	the	entire	compartment	in	which	the	tumour	was	located	
	
In	the	case	of	benign	bone	lesions	radical	resection	is	never	indicated	as	this	is	reserved	for	malignant	
tumours.	Wide,	marginal	and	intralesional	resection	techniques	have	all	been	described	in	the	
management	of	OO.		
	
f.	Bone	Graft	and	Bone	Substitutes	
Following	excision	of	a	bone	lesion	the	resultant	defect	may	need	to	be	addressed.	The	natural	cycle	of	
bone	formation	and	resorption	is	carried	out	by	osteoblasts,	osteocytes,	and	osteoclasts	under	the	
direction	of	the	bone-signaling	mediators.	This	will	result	in	remodelling	and	filling	of	a	bone	defect	but	
this	can	be	augmented	by	the	addition	of	bone	graft.	Not	all	bone	graft	and	bone	graft	substitutes	have	
the	same	properties	and	this	warrants	some	consideration.	The	four	fundamental	properties	of	bone	graft	
are	osteoconduction,	osteoinduction,	osteogenesis,	and	structural	support.	
Structural	bone	graft	imparts	mechanical	strength	to	the	surgical	defect.	The	structural	integrity	of	the	
bone	graft	material	may	change	with	time	as	resorbtion	occurs.		
An	osteoconductive	material	will	act	as	a	structural	framework	for	bone	growth.	
An	osteoinductive	material	contains	factors	that	stimulate	bone	growth	and	induction	of	stem	cells	down	
a	bone-forming	lineage.	An	osteogenic	material	directly	provides	cells	that	will	produce	bone.	This	
includes	primitive	mesenchymal	stem	cells,	osteoblasts,	and	osteocytes.	Mesenchymal	stem	cells	can	
potentially	differentiate	down	any	cell	line	while	osteoprogenitor	cells	differentiate	to	osteoblasts.	
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Autologous	bone	graft	(fresh	autograft	and	bone	marrow	aspirate)	is	the	only	bone	graft	material	that	
contains	live	mesenchymal	precursor	cells.	Autograft	can	be	cancellous,	cortical,	cortico-cancellous	and	
may	include	bone	graft	that	is	transposed	with	an	intact	blood	supply.	The	donor	locations	for	cancellous	
bone	graft	include	the	ilium	and	metaphyseal	regions	of	long	bones.	Cortical	graft,	which	is	used	where	
structural	support	is	of	critical	importance,	is	usually	harvested	from	fibula	or	ribs.	Another	source	is	the	
medullary	canal	of	the	femur	where	bone	graft	is	harvested	using	a	reamer-irrigator-aspirator	(RIA).	
Disadvantages	related	to	autograft	include	the	limitation	in	the	amount	that	can	be	harvested	and	the	
donor	site	morbidity.		
Allograft	is	harvested	from	human	cadaveric	donors.	It	is	available	in	many	forms	including	demineralized	
bone	matrix,	morselized	and	cancellous	chips,	corticocancellous	and	cortical	grafts,	osteochondral	and	
whole-bone	segments.	The	process	of	freeze-drying	(lyophilization)	allows	bone	to	be	stored	un-
refrigerated	for	prolonged	periods.	This	increases	the	availability	to	the	surgeon	as	it	can	be	used	as	an	
“off	the	shelf”	product.	Alternatively	fresh	frozen	graft	must	be	stored	at	sub-zero	temperatures	(-18	
degrees	Celsius)	for	up	to	1	year	while	deep	frozen	grafts	(-70	degrees	Celsius)	can	be	stored	for	up	to	5	
years.		Fresh	allograft	is	more	likely	to	induce	tissue	reaction	than	freeze	dried.		The	risk	of	transmission	of	
disease	from	donor	to	host	exists	with	allograft,	particularly	fresh	frozen,	while	the	process	of	preserving	
allograft	reduces	this	risk	significantly.	The	risk	of	HIV	transmission	is	quoted	as	1	in	1,5	million.	
Demineralised	bone	matrix	(DBM)	is	a	form	of	processed	allograft.	Allograft	bone	is	crushed	to	powder	
demineralized	by	submersion	in	hydrochloric	acid	and	washed	in	sterile	water,	ethanol	and	ethyl	ether	
leaving	the	protein	structure	and	growth	factors.	It	has	osteoconductive	and	osteoinductive	activity.	
Many	commercially	available	preparations	exist	but	there	is	no	evidence	to	demonstrate	superiority	of	
any	one	product.	DBM	may	be	combined	with	a	calcium	substrate,	such	as	calcium	sulphate	in	the	case	of	
Allomatrix	(Wright	Medical,	Middlesex,	UK).		
Ceramic	bone	graft	substitutes	include	calcium	phosphate,	tricalcium	phosphate,	hydroxyapatite	
(Ca10(PO4)6(OH)2	,	and	calcium	sulphate.	Coralline	or	structured	calcium	phosphate	is	structural	and	
osteoconductive	while	the	other	forms	of	ceramic	bone	graft	substitutes	are	osteoconductive	void	fillers	
and	are	suitable	for	contained	bone	defects	only.	These	may	be	in	the	form	of	paste,	pellets	or	injectable	
putty	and	may	be	used	as	a	delivery	vehicle	for	DBM	or	osteogenic	factors	such	as	bone	morphogenic	
proteins	(BMP),	bone	marrow	aspirate,	platelet	rich	plasma	(PRP)	or	collagen.	Bioactive	glass	is	a	
combination	of	silica,	calcium	oxide,	disodium	oxide,	and	pyrophosphate.	It	is	a	structural	ceramic	with	
osteoconductive	properties.	There	is	at	present	little	evidence	in	support	of	one	form	of	bone	graft	
substitute	over	another	and	autograft	remains	the	best	choice	but	at	the	cost	of	donor	site	morbidity.	The	
size	of	the	defect,	need	for	structural	support	and	availability	are	all	factors	which	dictate	the	choice	of	
graft	material.	
	
